Meta Biomed Co., Ltd. (KOSDAQ: 059210)
South Korea
· Delayed Price · Currency is KRW 3,975.00
+60.00 (1.53%)
Oct 14, 2024, 3:19 PM KST
Meta Biomed Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 11, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 89,540 | 99,718 | 52,832 | 66,184 | 64,352 | 64,799 | Upgrade
|
| Market Cap Growth | 1.26% | 88.74% | -20.17% | 2.85% | -0.69% | -6.02% | Upgrade
|
| Enterprise Value | 103,807 | 130,453 | 76,546 | 89,589 | 96,285 | 96,073 | Upgrade
|
| Last Close Price | 3915.00 | 4360.00 | 2298.92 | 2851.77 | 2751.90 | 2717.40 | Upgrade
|
| PE Ratio | 7.13 | 9.89 | 20.02 | 6.86 | -15.49 | 18.95 | Upgrade
|
| PS Ratio | 0.99 | 1.20 | 0.77 | 1.13 | 1.43 | 1.09 | Upgrade
|
| PB Ratio | 1.12 | 1.37 | 0.83 | 1.10 | 1.30 | 1.18 | Upgrade
|
| P/FCF Ratio | 14.99 | -78.43 | -8.47 | 7.30 | 24.43 | -13.80 | Upgrade
|
| P/OCF Ratio | 5.83 | 9.76 | 5.77 | 5.94 | 13.24 | 22.62 | Upgrade
|
| EV/Sales Ratio | 1.15 | 1.57 | 1.11 | 1.52 | 2.14 | 1.62 | Upgrade
|
| EV/EBITDA Ratio | 6.13 | 8.80 | 8.30 | 10.14 | 14.92 | 10.15 | Upgrade
|
| EV/EBIT Ratio | 8.41 | 12.30 | 14.27 | 17.03 | 38.30 | 16.70 | Upgrade
|
| EV/FCF Ratio | 17.37 | -102.60 | -12.28 | 9.88 | 36.55 | -20.46 | Upgrade
|
| Debt / Equity Ratio | 0.69 | 0.61 | 0.69 | 0.57 | 1.01 | 0.70 | Upgrade
|
| Debt / EBITDA Ratio | 3.36 | 3.00 | 4.78 | 3.90 | 7.73 | 4.06 | Upgrade
|
| Debt / FCF Ratio | 9.53 | -34.96 | -7.07 | 3.80 | 18.95 | -8.19 | Upgrade
|
| Asset Turnover | 0.61 | 0.66 | 0.61 | 0.56 | 0.43 | 0.59 | Upgrade
|
| Inventory Turnover | 3.25 | 2.99 | 2.65 | 2.10 | 1.58 | 2.35 | Upgrade
|
| Quick Ratio | 0.85 | 0.70 | 0.75 | 0.76 | 0.70 | 0.61 | Upgrade
|
| Current Ratio | 1.13 | 1.12 | 1.14 | 1.20 | 1.10 | 1.04 | Upgrade
|
| Return on Equity (ROE) | 19.34% | 14.74% | 4.61% | 17.37% | -5.91% | 10.84% | Upgrade
|
| Return on Assets (ROA) | 5.23% | 5.28% | 2.99% | 3.12% | 1.49% | 3.58% | Upgrade
|
| Return on Capital (ROIC) | 6.05% | 5.90% | 3.32% | 3.39% | 1.63% | 3.97% | Upgrade
|
| Earnings Yield | 14.09% | 10.11% | 4.97% | 14.39% | -6.36% | 5.16% | Upgrade
|
| FCF Yield | 6.67% | -1.28% | -11.80% | 13.70% | 4.09% | -7.25% | Upgrade
|
| Dividend Yield | 0.51% | 0.46% | 0.87% | 0.70% | 0.36% | 0.37% | Upgrade
|
| Payout Ratio | 3.09% | 4.54% | 17.43% | 2.41% | - | 6.97% | Upgrade
|
| Buyback Yield / Dilution | -6.71% | 0.06% | 0.07% | 0.61% | 1.08% | 0.68% | Upgrade
|
| Total Shareholder Return | -6.20% | 0.52% | 0.94% | 1.31% | 1.44% | 1.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.